EUVIMEDObjevte EUVIMED
FallberichtOpen access · CC BY-NC-ND 4.0

Positive clinical outcome using a modified dosing regimen of benznidazole in dogs at high risk for infection or acutely infected with Trypanosoma cruzi

Sukjung Lim iD, Stephanie Collins, Sarah A Hamer, Rick L Tarleton, Ashley B Saunders iD

Journal of Veterinary Internal Medicine · 2024

DOI: 10.1111/jvim.17028 ↗

At a glance

Fallbericht in Journal of Veterinary Internal Medicine, 2024. Written by Sukjung Lim and 4 co-authors. Institution: Department of Small Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, U…. Major MEDLINE topics: Nitroimidazoles, Dog Diseases, Chagas Disease, Trypanosoma cruzi. Cited 5 times so far (Crossref); 26 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NIH HHS, George Robinson Foundation, NCATS NIH HHS.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Trypanosoma cruzi infection in dogs can cause heart failure and sudden death with few treatment options available. A litter of 4 dogs living in a T cruzi endemic area were randomized to prophylaxis and nonprophylaxis groups as part of a study evaluating a modified benznidazole dosing regimen administered twice weekly to prevent T cruzi infection during a vector transmission season. The 2 dogs that received prophylaxis remained healthy without T cruzi infection or cardiac disease for >2 years. One dog that did not receive prophylaxis died unexpectedly with acute T cruzi–induced pancarditis, and the second dog tested positive for T cruzi and developed complex arrhythmias with markedly increased cardiac troponin I and improved with a higher benznidazole treatment dose. Although the small sample size precludes definitive conclusions, we describe the potential clinical benefit of prophylactic and early treatment with modified benznidazole dosing regimens for dogs with T cruzi infection.

Subjects

MeSH terms (MEDLINE)

NitroimidazolesDog DiseasesChagas DiseaseTrypanosoma cruziTrypanocidal AgentsDogsAnimalsFemaleMale

Author keywords

Chagas diseasemyocarditisprophylaxissudden deathtroponin

Substances

NitroimidazolesTrypanocidal Agentsbenzonidazole

Authors and institutions

  • Department of Small Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, USA.
  • Jourdanton, Texas, USA.
  • Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Research, Texas A&M University, College Station, Texas, USA.
  • Center for Tropical and Emerging Global Diseases and Department of Cellular Biology, University of Georgia, Athens, Georgia, USA.

ORCID profiles: Sukjung Lim, Ashley B Saunders

Funding

  • NIH HHS
  • George Robinson Foundation
  • NCATS NIH HHS
  • Veterinary Pharmacology Research Foundation
  • American Veterinary Medical Foundation
  • NIH

Cite

APA

Lim, S., Collins, S., Hamer, S. A., Tarleton, R. L., & Saunders, A. B. (2024). Positive clinical outcome using a modified dosing regimen of benznidazole in dogs at high risk for infection or acutely infected with Trypanosoma cruzi. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.17028

Vancouver

Lim S, Collins S, Hamer SA, Tarleton RL, Saunders AB. Positive clinical outcome using a modified dosing regimen of benznidazole in dogs at high risk for infection or acutely infected with Trypanosoma cruzi. Journal of Veterinary Internal Medicine. 2024. doi:10.1111/jvim.17028

BibTeX
@article{Lim2024,
  author = {Lim, Sukjung and Collins, Stephanie and Hamer, Sarah A and Tarleton, Rick L and Saunders, Ashley B},
  title = {Positive clinical outcome using a modified dosing regimen of benznidazole in dogs at high risk for infection or acutely infected with Trypanosoma cruzi},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2024},
  doi = {10.1111/jvim.17028}
}
Start for free →